317 related articles for article (PubMed ID: 35352319)
1. Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.
Perrine-Walker F
Braz J Microbiol; 2022 Sep; 53(3):1101-1113. PubMed ID: 35352319
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of caspofungin resistance in
De Cesare GB; Hafez A; Stead D; Llorens C; Munro CA
Virulence; 2022 Dec; 13(1):1005-1018. PubMed ID: 35730400
[No Abstract] [Full Text] [Related]
4. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
[TBL] [Abstract][Full Text] [Related]
5. Elevated chitin content reduces the susceptibility of Candida species to caspofungin.
Walker LA; Gow NA; Munro CA
Antimicrob Agents Chemother; 2013 Jan; 57(1):146-54. PubMed ID: 23089748
[TBL] [Abstract][Full Text] [Related]
6. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.
Pfaller M; Boyken L; Hollis R; Kroeger J; Messer S; Tendolkar S; Diekema D
J Clin Microbiol; 2011 Feb; 49(2):624-9. PubMed ID: 21147948
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro.
Lefranc M; Accoceberry I; Fitton-Ouhabi V; Biteau N; Noël T
J Antimicrob Chemother; 2024 Jan; 79(1):151-156. PubMed ID: 37991226
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Kovács R; Nagy F; Tóth Z; Bozó A; Balázs B; Majoros L
Lett Appl Microbiol; 2019 Oct; 69(4):271-278. PubMed ID: 31385615
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
[TBL] [Abstract][Full Text] [Related]
10. Emodin Reduces the Activity of (1,3)-
Janeczko M
Pol J Microbiol; 2018; 67(4):463-470. PubMed ID: 30550232
[TBL] [Abstract][Full Text] [Related]
11. Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species.
Locke JB; Almaguer AL; Zuill DE; Bartizal K
Antimicrob Agents Chemother; 2016 Oct; 60(10):6100-7. PubMed ID: 27480852
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity.
Sun Q; Xiong K; Yuan Y; Yu J; Yang L; Shen C; Su C; Lu Y
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791942
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
14. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.
Shirazi F; Kontoyiannis DP
Virulence; 2015; 6(4):385-94. PubMed ID: 26065323
[TBL] [Abstract][Full Text] [Related]
15. Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.
Eschenauer GA; Nguyen MH; Shoham S; Vazquez JA; Morris AJ; Pasculle WA; Kubin CJ; Klinker KP; Carver PL; Hanson KE; Chen S; Lam SW; Potoski BA; Clarke LG; Shields RK; Clancy CJ
Antimicrob Agents Chemother; 2014; 58(4):1897-906. PubMed ID: 24395235
[TBL] [Abstract][Full Text] [Related]
16. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.
Walraven CJ; Bernardo SM; Wiederhold NP; Lee SA
Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999
[TBL] [Abstract][Full Text] [Related]
18. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.
Axner-Elings M; Botero-Kleiven S; Jensen RH; Arendrup MC
J Clin Microbiol; 2011 Jul; 49(7):2516-21. PubMed ID: 21543574
[TBL] [Abstract][Full Text] [Related]
19. Caspofungin-induced β(1,3)-glucan exposure in
Wagner AS; Lumsdaine SW; Mangrum MM; Reynolds TB
mBio; 2023 Aug; 14(4):e0007423. PubMed ID: 37377417
[TBL] [Abstract][Full Text] [Related]
20. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
